Sonal S Munsiff

Summary

Country: USA

Publications

  1. pmc Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997
    Sonal S Munsiff
    New York City Department of Health, New York, New York 10013, USA
    Emerg Infect Dis 8:1230-8. 2002
  2. ncbi request reprint Rifapentine for the treatment of pulmonary tuberculosis
    Sonal S Munsiff
    New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 43:1468-75. 2006
  3. ncbi request reprint Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999
    Sonal S Munsiff
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA
    J Infect Dis 188:356-63. 2003
  4. ncbi request reprint Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003
    Sonal S Munsiff
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 42:1702-10. 2006
  5. pmc Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004
    Michelle Macaraig
    New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
    J Clin Microbiol 44:2890-6. 2006
  6. pmc Universal genotyping in tuberculosis control program, New York City, 2001-2003
    Carla M Clark
    Tuberculosis Control Program, New York City Department of Health and Mental Hygiene, 225 Broadway, New York, NY 10007, USA
    Emerg Infect Dis 12:719-24. 2006
  7. ncbi request reprint Which patients' factors predict the rate of growth of Mycobacterium tuberculosis clusters in an urban community?
    Cynthia R Driver
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Am J Epidemiol 164:21-31. 2006
  8. ncbi request reprint Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costs
    Jiehui Li
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 1007, USA
    J Public Health Manag Pract 13:252-62. 2007
  9. ncbi request reprint Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001
    Sharlette Cook
    New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York City, New York 10013, USA
    Infect Control Hosp Epidemiol 24:807-13. 2003
  10. ncbi request reprint Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000
    Jiehui Li
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 41:83-91. 2005

Detail Information

Publications31

  1. pmc Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997
    Sonal S Munsiff
    New York City Department of Health, New York, New York 10013, USA
    Emerg Infect Dis 8:1230-8. 2002
    ..8%) patients; most had been exposed to patients diagnosed before the study period. These strains were likely transmitted in the early 1990 s when MDRTB outbreaks and tuberculosis transmission were widespread in New York...
  2. ncbi request reprint Rifapentine for the treatment of pulmonary tuberculosis
    Sonal S Munsiff
    New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 43:1468-75. 2006
    ..As with rifampin, drug-drug interactions are common, and regular patient monitoring is required. Ease of administration makes this regimen attractive both for tuberculosis-control programs and for patients...
  3. ncbi request reprint Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999
    Sonal S Munsiff
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA
    J Infect Dis 188:356-63. 2003
    ..This strain was disseminated widely in the community during the outbreaks; postoutbreak cases likely represent reactivated disease among individuals infected during the outbreak periods in the community...
  4. ncbi request reprint Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003
    Sonal S Munsiff
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 42:1702-10. 2006
    ..Two drug-resistance surveys showed a very high prevalence of drug resistance among isolates obtained from patients with tuberculosis in 1991 and 1994 in New York, New York...
  5. pmc Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004
    Michelle Macaraig
    New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
    J Clin Microbiol 44:2890-6. 2006
    ....
  6. pmc Universal genotyping in tuberculosis control program, New York City, 2001-2003
    Carla M Clark
    Tuberculosis Control Program, New York City Department of Health and Mental Hygiene, 225 Broadway, New York, NY 10007, USA
    Emerg Infect Dis 12:719-24. 2006
    ..Four additional TB cases were identified as a result of case finding initiated through cluster investigations. Length of unnecessary treatment decreased among patients with false-positive cultures...
  7. ncbi request reprint Which patients' factors predict the rate of growth of Mycobacterium tuberculosis clusters in an urban community?
    Cynthia R Driver
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Am J Epidemiol 164:21-31. 2006
    ..78). The rate of genotype cluster growth should be monitored regardless of how long the strain has been present in the community. However, infectiousness in the first two cases may be useful to prioritize genotype cluster investigations...
  8. ncbi request reprint Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costs
    Jiehui Li
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 1007, USA
    J Public Health Manag Pract 13:252-62. 2007
    ....
  9. ncbi request reprint Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001
    Sharlette Cook
    New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York City, New York 10013, USA
    Infect Control Hosp Epidemiol 24:807-13. 2003
    ..To determine the prevalence of and risk factors for tuberculin skin test positivity and conversion among New York City Department of Health and Mental Hygiene employees...
  10. ncbi request reprint Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000
    Jiehui Li
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
    Clin Infect Dis 41:83-91. 2005
    ..The relationship between rifamycin use and either relapse or treatment failure with acquired rifampin resistance (ARR) among human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) is not well understood...
  11. ncbi request reprint Tuberculosis in health care workers during declining tuberculosis incidence in New York State
    Cynthia R Driver
    Bureau of Tuberculosis Control, Department of Health and Mental Hygiene, New York, NY, USA
    Am J Infect Control 33:519-26. 2005
    ..Nosocomial tuberculosis (TB) transmission has decreased dramatically in New York State since 1992; however, health care workers (HCWs) still compose >3% of TB cases...
  12. pmc Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009
    Bianca R Perri
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, CN 72B, New York, NY 10007, USA
    Emerg Infect Dis 17:372-8. 2011
    ..tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved...
  13. ncbi request reprint Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs
    Jerod N Scholten
    New York City Department of Health and Mental Hygiene, New York, USA
    Clin Infect Dis 37:1686-92. 2003
    ..6; 95% CI, 1.02-57.1); a CD4+ T lymphocyte count of <200 cells/mm3 (HR 6.6; 95% CI, 1.7-25.9); and tuberculin positivity (HR 4.0; 95% CI, 1.6-10.2). Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs...
  14. doi request reprint Adherence to treatment of latent tuberculosis infection in a clinical population in New York City
    Jiehui Li
    New York City Department of Health and Mental Hygiene NYCDOHMH, 26th Floor, New York, NY 10279 2600, USA
    Int J Infect Dis 14:e292-7. 2010
    ..Low adherence to treatment of latent tuberculosis infection (TLTBI) diminishes TB prevention efforts. This study examined the treatment completion rate among those who started TLTBI and factors associated with adherence to TLTBI...
  15. ncbi request reprint Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren
    Celine R Gounder
    Tuberculosis Control Program, New York City Department of Health, New York, New York 10007, USA
    Pediatrics 111:e309-15. 2003
    ..To assess adherence to a 1996 health policy change, which discontinued mandatory tuberculin skin testing (TST) of new entrants to NYC primary schools and continued mandatory testing of new entrants to secondary schools...
  16. doi request reprint Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting
    Fabienne Laraque
    Bureau of Tuberculosis Control, New York City Department of Health of Mental Hygiene, New York 10013, USA
    Clin Infect Dis 49:46-54. 2009
    ..We evaluated the performance of NAA testing under field conditions in a large urban setting with moderate TB prevalence...
  17. ncbi request reprint Tuberculosis
    Thomas R Frieden
    New York City Department of Health and Mental Hygiene, New York, NY 10013, USA
    Lancet 362:887-99. 2003
    ..Until tuberculosis is controlled worldwide, it will continue to be a major killer in less-developed countries and a constant threat in most of the more-developed countries...
  18. doi request reprint Prevalence of tuberculin skin test positivity in clinical population in New York City
    Jiehui Li
    New York City Department of Health and Mental Hygiene, New York, NY 10279 2600, USA
    J Immigr Minor Health 12:816-22. 2010
    ..3, 95%CI = 1.2, 1.4). These findings provide insight into current prevalence of TST positivity in many immigrant populations and will help both clinicians and health departments to target patients for LTBI treatment...
  19. doi request reprint Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
    Holly A Anger
    New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, 225 Broadway, 22nd Floor, New York, NY 10007, USA
    J Antimicrob Chemother 65:775-83. 2010
    ....
  20. ncbi request reprint Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients
    Jiehui Li
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
    Chest 126:1770-6. 2004
    ....
  21. doi request reprint Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005
    Tiffany G Harris
    New York City Department of Health and Mental Hygiene, New York, New York, USA
    Clin Infect Dis 50:1524-31. 2010
    ..Although highly active antiretroviral therapy (HAART) has decreased human immunodeficiency virus (HIV)-related morbidity, tuberculosis remains an important disease among HIV-infected individuals...
  22. ncbi request reprint Factors associated with tuberculosis treatment interruption in New York City
    Cynthia R Driver
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
    J Public Health Manag Pract 11:361-8. 2005
    ..Large urban tuberculosis control program...
  23. doi request reprint The impact of monitoring tuberculosis reporting delays in New York City
    Muriel Silin
    New York City Department of Health and Mental Hygiene NYC DOHMH, Bureau of TB Control, New York 10007, USA
    J Public Health Manag Pract 16:E09-17. 2010
    ..This relatively simple intervention was very effective in improving the timeliness of TB reporting and could be utilized for other reportable diseases where prompt reporting is critical...
  24. ncbi request reprint The DOTS strategy for controlling the global tuberculosis epidemic
    Thomas R Frieden
    New York City Department of Health and Mental Hygiene, 125 Worth Street, New York, NY 10013, USA
    Clin Chest Med 26:197-205, v. 2005
    ..The relevance of DOTS in the context of multidrug-resistant tuberculosis and the HIV epidemic also is discussed...
  25. pmc Targeting tuberculosis testing: the yield of source case investigations for young children with reactive tuberculin skin tests
    Cynthia R Driver
    Tuberculosis Control Program, New York City Department of Health, New York, NY 10007, USA
    Public Health Rep 117:366-72. 2002
    ..This study was designed to determine the yield of investigations whose aim is to identify a source case for tuberculosis infection among tuberculin reactors 3 years of age or younger...
  26. ncbi request reprint Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997
    Thomas R Frieden
    Int J Tuberc Lung Dis 11:116. 2007
  27. ncbi request reprint Management of latent tuberculosis infection in immigrants
    Timothy Sterling
    N Engl J Med 348:1289-92; author reply 1289-92. 2003
  28. ncbi request reprint Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
    William J Burman
    Denver Public Health and the Department of Medicine, University of Colorado Health Sciences National Jewish Medical and Research Center, Denver, Colorado, USA
    Am J Respir Crit Care Med 174:331-8. 2006
    ..Moxifloxacin has promising preclinical activity against Mycobacterium tuberculosis, but has not been evaluated in multidrug treatment of tuberculosis in humans...
  29. ncbi request reprint Patients with drug-resistant tuberculosis who were treated with standardized short-course chemotherapy
    Sonal S Munsiff
    Clin Infect Dis 40:1549-50. 2005
  30. ncbi request reprint Tuberculosis prevention for non-US-born pregnant women
    Judith E Sackoff
    Department of Medicine Preventive Medicine and Community Health, State University of New York Downstate Medical Center, Brooklyn, NY, USA
    Am J Obstet Gynecol 194:451-6. 2006
    ..The purpose of this study was to evaluate whether non-US-born pregnant women receiving prenatal care are targeted for treatment of latent tuberculosis (TB) infection (LTBI) with isoniazid (INH) to prevent active TB...
  31. ncbi request reprint How late after injection can a tuberculin skin test be interpreted?
    Sonal S Munsiff
    Clin Infect Dis 41:271; author reply 271. 2005